Showing results (81-90 of 211) with videos related to

Sort By:
Pageof 22
Hematological Oncology|July 31, 2019
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approachAlessandra Iurlo, Elena Maria Elli, Francesca Palandri, et al.
Annals of Hematology|November 29, 2024
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE studySimona Bernardi, Alessia Cavalleri, Silvia Mutti, et al.
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Frontiers in Psychology|March 8, 2019
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical TrialLidia Borghi, Sara Galimberti, Claudia Baratè, et al.
Small (Weinheim an Der Bergstrasse, Germany)|January 30, 2026
Thermo-Chemically Modified Silk Scaffolds Reveal Niche-Driven Regulation of Hematopoiesis and FibrosisChristian A Di Buduo, Carolina P Miguel, Giulia Della Rosa, et al.
BMC Cancer|August 4, 2016
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutantsSimona Soverini, Caterina De Benedittis, Fausto Castagnetti, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 9, 2013
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasmsUmberto Gianelli, Anna Bossi, Ivan Cortinovis, et al.
Blood|November 8, 2019
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasmsChristian A Di Buduo, Vittorio Abbonante, Caroline Marty, et al.
The Journal of Experimental Medicine|February 9, 2019
EDA fibronectin-TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosisAlessandro Malara, Cristian Gruppi, Vittorio Abbonante, et al.
Drug Design, Development and Therapy|June 2, 2015
Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating studyNicola Cascavilla, Valerio De Stefano, Fabrizio Pane, et al.
Pageof 22